Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Scientific Reports
|
October 11, 2018
Microclimate exerts greater control over litter decomposition and enzyme activity than litter quality in an alpine forest-tundra ecotone
Yamei Chen, Yang Liu, Jian Zhang, et al.
Expert Review of Anticancer Therapy
|
December 5, 2015
Will new drugs change the standard of care for patients with mantle cell lymphoma?
Donald S Colbourn, Jennifer E Amengual, Changchun Deng, et al.
Haematologica
|
March 26, 2017
Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant <i>MYD88</i> and wildtype <i>CD79</i>
Andrew L Deng, Yu Ri Kim, Emily A Lichtenstein, et al.
BMC Medical Education
|
October 19, 2006
The research rotation: competency-based structured and novel approach to research training of internal medicine residents
Balavenkatesh Kanna, Changchun Deng, Savil N Erickson, et al.
Soft Matter
|
September 9, 2020
Solvent-filled matrix polyelectrolyte capsules: preparation, structure and dynamics
Changchun Deng, Wen-Fei Dong, Thorsteinn Adalsteinsson, et al.
Oncotarget
|
September 25, 2020
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest
Luigi Scotto, Xavier J Serrano, Kelly Zullo, et al.
Therapeutic Advances in Hematology
|
October 16, 2020
Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series
Helen Ma, Bin Cheng, Francesca Montanari, et al.
Blood Advances
|
May 25, 2022
Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity
Ipsita Pal, Andre M Sardinha Grilo, Alec Gaspary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2014
The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB
Changchun Deng, Mark Lipstein, Richard Rodriguez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 6, 2025
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
Dandan Yuan, Yali Gao, Lin Xia, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Scientific Reports
|
October 11, 2018
Microclimate exerts greater control over litter decomposition and enzyme activity than litter quality in an alpine forest-tundra ecotone
Yamei Chen, Yang Liu, Jian Zhang, et al.
Expert Review of Anticancer Therapy
|
December 5, 2015
Will new drugs change the standard of care for patients with mantle cell lymphoma?
Donald S Colbourn, Jennifer E Amengual, Changchun Deng, et al.
Haematologica
|
March 26, 2017
Combination of ibrutinib and chemotherapy produced a durable remission in multiply relapsed diffuse large B-cell lymphoma leg type with mutant <i>MYD88</i> and wildtype <i>CD79</i>
Andrew L Deng, Yu Ri Kim, Emily A Lichtenstein, et al.
BMC Medical Education
|
October 19, 2006
The research rotation: competency-based structured and novel approach to research training of internal medicine residents
Balavenkatesh Kanna, Changchun Deng, Savil N Erickson, et al.
Soft Matter
|
September 9, 2020
Solvent-filled matrix polyelectrolyte capsules: preparation, structure and dynamics
Changchun Deng, Wen-Fei Dong, Thorsteinn Adalsteinsson, et al.
Oncotarget
|
September 25, 2020
ATM inhibition overcomes resistance to histone deacetylase inhibitor due to p21 induction and cell cycle arrest
Luigi Scotto, Xavier J Serrano, Kelly Zullo, et al.
Therapeutic Advances in Hematology
|
October 16, 2020
Low dose continuous lenalidomide in heavily pretreated patients with relapsed or refractory classical Hodgkin lymphoma: a retrospective case series
Helen Ma, Bin Cheng, Francesca Montanari, et al.
Blood Advances
|
May 25, 2022
Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity
Ipsita Pal, Andre M Sardinha Grilo, Alec Gaspary, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 2014
The novel IKK2 inhibitor LY2409881 potently synergizes with histone deacetylase inhibitors in preclinical models of lymphoma through the downregulation of NF-κB
Changchun Deng, Mark Lipstein, Richard Rodriguez, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
February 6, 2025
Discovery of novel biphenyl compounds bearing hydroxamic acid moiety as the first PD-L1/class I HDACs dual inhibitors
Dandan Yuan, Yali Gao, Lin Xia, et al.
Page
of 4